Cargando…
Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells
The scattering response of epithelial cells to activation of the Met receptor tyrosine kinase represents one facet of an “invasive growth” program [1, 2]. It is a complex event that incorporates loss of cell-cell adhesion, morphological changes, and cell motility. Ubiquitination is a reversible post...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764384/ https://www.ncbi.nlm.nih.gov/pubmed/19699092 http://dx.doi.org/10.1016/j.cub.2009.07.040 |
_version_ | 1782173076859912192 |
---|---|
author | Buus, Richard Faronato, Monica Hammond, Dean E. Urbé, Sylvie Clague, Michael J. |
author_facet | Buus, Richard Faronato, Monica Hammond, Dean E. Urbé, Sylvie Clague, Michael J. |
author_sort | Buus, Richard |
collection | PubMed |
description | The scattering response of epithelial cells to activation of the Met receptor tyrosine kinase represents one facet of an “invasive growth” program [1, 2]. It is a complex event that incorporates loss of cell-cell adhesion, morphological changes, and cell motility. Ubiquitination is a reversible posttranslational modification that may target proteins for degradation or coordinate signal transduction pathways [3, 4]. There are ∼79 active deubiquitinating enzymes (DUBs) predicted in the human genome [5, 6]. Here, via a small interfering RNA (siRNA) library approach, we have identified 12 DUBs that are necessary for aspects of the hepatocyte growth factor (HGF)-dependent scattering response of A549 cells. Different phenotypes are evident that range from full loss of scattering, similar to receptor knockdown (e.g., USP30, USP33, USP47), to loss of cell-cell contacts even in the absence of HGF but defective motility (e.g., USP3, ATXN3L). The knockdowns do not incur defective receptor, phosphatidylinositol 3-kinase, or MAP kinase activation. Our data suggest widespread involvement of the ubiquitin system at multiple stages of the Met activation response, implying significant crosstalk with phosphorylation-based transduction pathways. Development of small-molecule inhibitors of particular DUBs may offer a therapeutic approach to contain metastasis. |
format | Text |
id | pubmed-2764384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-27643842009-10-23 Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells Buus, Richard Faronato, Monica Hammond, Dean E. Urbé, Sylvie Clague, Michael J. Curr Biol Report The scattering response of epithelial cells to activation of the Met receptor tyrosine kinase represents one facet of an “invasive growth” program [1, 2]. It is a complex event that incorporates loss of cell-cell adhesion, morphological changes, and cell motility. Ubiquitination is a reversible posttranslational modification that may target proteins for degradation or coordinate signal transduction pathways [3, 4]. There are ∼79 active deubiquitinating enzymes (DUBs) predicted in the human genome [5, 6]. Here, via a small interfering RNA (siRNA) library approach, we have identified 12 DUBs that are necessary for aspects of the hepatocyte growth factor (HGF)-dependent scattering response of A549 cells. Different phenotypes are evident that range from full loss of scattering, similar to receptor knockdown (e.g., USP30, USP33, USP47), to loss of cell-cell contacts even in the absence of HGF but defective motility (e.g., USP3, ATXN3L). The knockdowns do not incur defective receptor, phosphatidylinositol 3-kinase, or MAP kinase activation. Our data suggest widespread involvement of the ubiquitin system at multiple stages of the Met activation response, implying significant crosstalk with phosphorylation-based transduction pathways. Development of small-molecule inhibitors of particular DUBs may offer a therapeutic approach to contain metastasis. Cell Press 2009-09-15 /pmc/articles/PMC2764384/ /pubmed/19699092 http://dx.doi.org/10.1016/j.cub.2009.07.040 Text en © 2009 ELL & Excerpta Medica. https://creativecommons.org/licenses/by/3.0/ Open Access under CC BY 3.0 (https://creativecommons.org/licenses/by/3.0/) license |
spellingShingle | Report Buus, Richard Faronato, Monica Hammond, Dean E. Urbé, Sylvie Clague, Michael J. Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title | Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title_full | Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title_fullStr | Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title_full_unstemmed | Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title_short | Deubiquitinase Activities Required for Hepatocyte Growth Factor-Induced Scattering of Epithelial Cells |
title_sort | deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764384/ https://www.ncbi.nlm.nih.gov/pubmed/19699092 http://dx.doi.org/10.1016/j.cub.2009.07.040 |
work_keys_str_mv | AT buusrichard deubiquitinaseactivitiesrequiredforhepatocytegrowthfactorinducedscatteringofepithelialcells AT faronatomonica deubiquitinaseactivitiesrequiredforhepatocytegrowthfactorinducedscatteringofepithelialcells AT hammonddeane deubiquitinaseactivitiesrequiredforhepatocytegrowthfactorinducedscatteringofepithelialcells AT urbesylvie deubiquitinaseactivitiesrequiredforhepatocytegrowthfactorinducedscatteringofepithelialcells AT claguemichaelj deubiquitinaseactivitiesrequiredforhepatocytegrowthfactorinducedscatteringofepithelialcells |